Maravai LifeSciences Holdings Inc
(NAS:MRVI)
$
5.92
0.3 (5.34%)
Market Cap: 839.71 Mil
Enterprise Value: 780.08 Mil
PE Ratio: 0
PB Ratio: 2.43
GF Score: 74/100 Maravai LifeSciences Holdings Inc at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual) Transcript
Mar 21, 2023 / 04:45PM GMT
Release Date Price:
$14.18
(-0.42%)
Paul Richard Knight
KeyBanc Capital Markets Inc., Research Division - MD & Senior Analyst
Hi, this is Paul Knight, the analyst at KeyBanc on life science tools, covering Maravai. It's a pleasure today to have Carl Hull talking about business in the world of mRNA and related programs. So welcome to the conference, Carl.
Carl W. Hull
Maravai LifeSciences Holdings, Inc. - Co-Founder and Executive Chairman & Interim CEO
Well, thank you, Paul. It's good to be with you.
Paul Richard Knight
KeyBanc Capital Markets Inc., Research Division - MD & Senior Analyst
If you want to make a couple of opening comments, that's great, and you can start with why is the rain in California, but...
Carl W. Hull
Maravai LifeSciences Holdings, Inc. - Co-Founder and Executive Chairman & Interim CEO
Well, you mean an atmospheric rivers are the problem the reason. No, look, I'm happy to field any questions or give your audience an overview of Maravai, whichever way you'd like to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot